Public Health Genomics Webinar
This web page is archived for historical purposes and is no longer being maintained or updated.
The Role of Cost-Effectiveness Analysis in Precision Medicine and Public Health Genomics
March 27, 2018, 10:00-11:30 am EST
CDC Chamblee Campus, Chamblee Campus Bldg 102 RM 2202
Free Registration is required. REGISTER NOW
Mark your Calendar to View the Webinar via Skype
Join by Phone: (885) 644-0229- Conference ID: 4390261
Scott Grosse, PhD
Health Economist, National Center on Birth Defects and Developmental Disabilities,
Centers for Disease Control and Prevention
- Whiting P et al. Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis.External Health Technol Assess. 2014 Mar;18(18):1-106
- Grosse SD, Khoury MJ. Epidemiology matters: peering inside the “black box” in economic evaluations of genetic testing.External Genet Med. 2016 Oct;18(10):963-5.